Pharming Group N.V. Admission to listing and trading of at least 100 million newly issued ordinary shares with a nominal value of €0.04 per share and with an offer price of €0.12 per share (the ‘Securities Note and Summary’)
Below you will find information from the register approved prospectuses. The information has been provided by the organisation.
                                    Date approval
                                    
                                            27 may 2010
                                    
                                
                            
                                    Issuing institution
                                    
                                            Pharming Group N.V.
                                    
                                
                            
                                    Description
                                    
                                            Admission to listing and trading of at least 100 million newly issued ordinary shares with a nominal value of €0.04 per share and with an offer price of €0.12 per share (the ‘Securities Note and Summary’)
                                    
                                
                            
                                    Filetype
                                    
                                            Verrichtingennota met samenvatting
                                    
                                
                            
                                    Date of entrance
                                    
                                            29 may 2010
                                    
                                
                            
                                    Type of publication
                                    
                                            Elektronisch
                                    
                                
                            
                                    Place of publication
                                    
                                            After approval, the Registration Document can be obtained via: www.pharming.com
                                    
                                
                            Date last update: 31 October 2025